Literature DB >> 27578030

A case of falciparum malaria: Acute hearing loss as the initial symptom.

Takeshi Tada1, Akihiro Hitani2, Natsue Hosono Honda2, Shinichi Haruna3, Tsuyoshi Yoshimura1, Kosuke Haruki2, Yasuhiro Tanaka4.   

Abstract

A 49-year-old healthy woman, who returned from Burkina Faso, visited an ear, nose, and throat clinic with complaints of left hearing loss, tinnitus, and dizziness. Pure tone audiometry demonstrated bilateral mild sensorineural hearing loss. Three days later, she was transported in an ambulance to a general hospital due to high fever and disturbance of consciousness. Plasmodium falciparum was found in the peripheral blood smear. After diagnosing severe falciparum malaria with cerebral involvement, quinine hydrochloride, clindamycin, and artemether/lumefantrine were administered. After recovery of consciousness, she was followed up at our department with bilateral hearing loss. After taking prednisolone for 10 days, there was improvement to normal hearing level. Furthermore, no neurologic sequelae were observed. In this case, acute sensorineural hearing loss occurred before administration of the antimalarial drug. Therefore, hearing loss was not drug-induced, but was caused by the malaria itself. In patients with acute hearing loss and who have history of travel to tropical regions, physicians should include malaria and other causes of acute deafness in the differential diagnoses.
Copyright © 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ABR; Cerebral malaria; Deafness; MRI

Mesh:

Substances:

Year:  2016        PMID: 27578030     DOI: 10.1016/j.jiac.2016.07.016

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  1 in total

1.  Cerebral Malaria: Hear before Discharge!

Authors:  Ambarish Joshi; Nitesh Gupta; Pranav Ish; Shibdas Chakrabarti
Journal:  Indian J Crit Care Med       Date:  2020-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.